Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPersonalized medicine: Factors influencing reimbursement
Health Policy, 10/12/09
Meckley LM et al. – To date, the promise and hype of PM has outpaced its evidentiary support. In order to achieve favorable coverage and reimbursement and to support premium prices for PM, manufacturers will need to bring better clinical evidence to the marketplace and better establish the value of their products.
Related Articles
Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment
Health Policy, 11/12/09
Relevance Score: 65%
Monetary incentives for schizophrenia
Cochrane Reviews, 10/28/09
Relevance Score: 43%
Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT)
BMC Psychiatry, 10/02/09
Relevance Score: 43%
Family Physician attitudes about prescribing using a drug formulary
BMC Family Practice, 10/20/09
Relevance Score: 42%
Sonographer practitioner development in Australia: Qualitative analysis of an Australian sonographers' survey
Radiography, 10/01/09
Relevance Score: 42%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Understanding the Economic Impact of a Pandemic
AMN Healthcare, 12/17/09
HHS Gets Advice on Incentive Definitions
HealthDataManagement, 12/16/09
Presidential order targets improper federal payments
American Hospital Association News, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor